Premature Ovarian Insufficiency
Conditions
Interventions
Control group:Chinese medicine
Observation groups:Acupuncture + Chinese medicine
Sponsors
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: (1)Age 18-40 years; (2)Combined with the diagnostic standards of traditional Chinese medicine and Western medicine; (3)No medications for the treatment of this disease have been used in the past three months; (4)Patients who voluntarily participated in this study and had good adherence.
Exclusion criteria
Exclusion criteria: (1)Combined with reproductive tract development abnormalities, reproductive system tuberculosis, Asherman syndrome, polycystic ovary syndrome, thyroid disease, empty sella syndrome, central nervous system tumors, ovarian resistance syndrome, etc; (2)Patients with serious diseases such as cardiovascular and cerebrovascular diseases, liver, kidneys, and hematopoietic system, diabetes mellitus, or blood sugar abnormalities; (3)In the past 3 months, patients have been treated with traditional Chinese medicines or hormone drugs that are of the same kind, related to, or antagonistic to the drugs used in this institute; (4)Pregnant and lactating patients; (5)People who are allergic to research drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Follicle-stimulating hormone;Anti-Müller tube hormone; | — |
Countries
China
Contacts
Public ContactLi Yanhong
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed